Daxiang Biotech has joined Scientist.com as a Registered Supplier, creating a new way for pharmaceutical, biotech, and research organizations worldwide to access its organoid, organoid-on-chip, and microphysiological system (MPS) technologies and research services.

The move expands Daxiang’s global reach and gives researchers another channel to discover its capabilities, connect with the team, and explore potential research collaborations.

Connecting with Global Life Science R&D

Scientist.com is a global life science R&D platform that connects pharmaceutical, biotech, and other research organizations with external scientific products and services.

As a Registered Supplier, Daxiang can showcase its capabilities to research teams using the platform to identify external partners and source services for drug discovery and development.

For Daxiang, joining Scientist.com is part of a broader effort to make its human-relevant models and research capabilities more accessible to the global life science community.

Supporting Drug Development with Organoid-on-Chip and MPS Technologies

Daxiang Biotech specializes in the development and application of organoid, organoid-on-chip, and microphysiological system (MPS) technologies.

Built around its Organoid-on-Chip + AI + Automation technology framework, Daxiang has developed an integrated portfolio spanning proprietary instruments, chips, reagents, physiological and disease models, and research services. These capabilities support a range of applications across drug discovery, preclinical development, and translational research.

Daxiang’s capabilities include:

• Oncology and immuno-oncology — Patient-derived organoid (PDO) and advanced co-culture models for drug efficacy testing, tumor microenvironment studies, and immunotherapy research
• Drug safety and toxicity assessment — Human-relevant liver, cardiac, kidney, intestinal, and other models for evaluating potential drug-induced toxicity
• Barrier and transport studies — In vitro blood-brain barrier (BBB), intestinal barrier, and other models for permeability, transport, and mechanistic studies
• Disease modeling and efficacy studies — Physiologically and pathologically relevant human models for compound screening, efficacy evaluation, and mechanism-of-action studies
• Customized research services — Organoid and organoid-on-chip model development and research services tailored to specific research needs

By recreating key aspects of human physiology and disease in vitro, these models can help generate more human-relevant data and support better-informed decisions throughout the drug development process.

Expanding Global Collaboration

Organoids, organ-on-chip technologies, and MPS are becoming increasingly important tools in the development of New Approach Methodologies (NAMs), as researchers look for more predictive and human-relevant approaches to biomedical research and drug development.

Against this backdrop, Daxiang is continuing to expand its international presence and build new connections with pharmaceutical and biotech companies, research institutions, and other partners across the global life science community.

Joining Scientist.com adds another channel for researchers worldwide to discover and access Daxiang’s technologies and services.

Looking ahead, Daxiang will continue to advance its Organoid-on-Chip + AI + Automation platform and broaden the application of human-relevant in vitro models across drug discovery, efficacy testing, safety assessment, and translational research.

About Daxiang Biotech

Founded in 2018, Daxiang Biotech develops organoid-on-chip and microphysiological system (MPS) technologies for drug discovery, translational research, and precision medicine.

Built around its Organoid-on-Chip + AI + Automation technology framework, Daxiang has established an integrated portfolio of proprietary instruments, chips, reagents, physiological and disease models, and research services. The company works with pharmaceutical and biotechnology companies, research institutions, and other life science organizations to advance the use of more predictive, human-relevant models in biomedical research and drug development.

Researchers and organizations interested in working with Daxiang Biotech can find Daxiang on Scientist.com or contact our team to discuss potential projects and collaborations.